Savara SVRA
NASDAQ SVRA
$4.85 -0.20 (-3.87%)
As of: Oct 2, 2026 · 11:42 AM EDT

Savara (SVRA) Return on Equity [ROE] (2011 - 2026)

Updated

Savara's Return on Equity [ROE] was -89.85% in Q2 2026, down 3.68 percentage points from -86.17% a year earlier and down 19.12 percentage points from the prior quarter.

Analysis

Savara (SVRA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Savara came in at -65.97%, up 0.22 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of -6.60 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -66.19% in FY2024 (-17.83 pp), -48.36% in FY2023 (-17.57 pp), -30.79% in FY2022 (+8.92 pp) and -39.71% in FY2021 (+19.66 pp).
  • Quarterly Return on Equity [ROE] has moved between -111.24% (Q3 2025) and -27.35% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has declined for 17 straight quarters, with an average year-over-year change of -17.93 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 56.57 percentage points); the worst was Q3 2025 (a drop of 53.10 percentage points).
  • Per Business Quant data, SVRA's Return on Equity [ROE] in the three quarters before Q2 2026 was -70.74% (Q1 2026), -81.85% (Q4 2025) and -111.24% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Savara 1.06 Bn 1.06 Bn - -89.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -89.85%
Mar 31, 2026 -70.74%
Dec 31, 2025 -81.85%
Sep 30, 2025 -111.24%
Jun 30, 2025 -86.17%
Mar 31, 2025 -67.25%
Dec 31, 2024 -54.51%
Sep 30, 2024 -58.14%
Jun 30, 2024 -70.85%
Mar 31, 2024 -52.05%
Dec 31, 2023 -41.83%
Sep 30, 2023 -45.46%
Jun 30, 2023 -49.19%
Mar 31, 2023 -41.65%
Dec 31, 2022 -34.63%
Sep 30, 2022 -31.70%
Jun 30, 2022 -28.87%
Mar 31, 2022 -27.84%
Dec 31, 2021 -27.68%
Sep 30, 2021 -27.35%
API Access

Savara Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SVRA&period=max&api_key=YOUR_API_KEY